ANIX

Anixa Biosciences Inc

Anixa Biosciences Inc (ANIX) has 3 SEC Form 4 filings (3 transaction rows) in the rolling window, disclosed by 2 distinct insiders. Most recent filing: Jul 16, 2026.

  • Industry:Biotechnology
  • CEO:Amit Kumar
  • Employees:5
  • HQ:San Jose, CA, US
  • IPO:1983-10-07

Insider Buying

$32K

reported purchases (SEC code P)

Insider Selling

$0

reported sales (SEC code S)

Unique Insiders

2

in the rolling window

Market Cap

$113.0M

latest known value

Source
Purchase$9KJul 16SEC ↗
KUMAR AMITFirst filing
Purchase$15KJul 13SEC ↗
Purchase$7KJun 17SEC ↗

Related companies

Anixa Biosciences Inc is in the Healthcare sector.